Correlation Between Dupont De and Inozyme Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Inozyme Pharma, you can compare the effects of market volatilities on Dupont De and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Inozyme Pharma.

Diversification Opportunities for Dupont De and Inozyme Pharma

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Dupont and Inozyme is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Dupont De i.e., Dupont De and Inozyme Pharma go up and down completely randomly.

Pair Corralation between Dupont De and Inozyme Pharma

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.43 times more return on investment than Inozyme Pharma. However, Dupont De Nemours is 2.34 times less risky than Inozyme Pharma. It trades about -0.01 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.66 per unit of risk. If you would invest  8,391  in Dupont De Nemours on August 27, 2024 and sell it today you would lose (59.00) from holding Dupont De Nemours or give up 0.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dupont De Nemours  vs.  Inozyme Pharma

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Dupont De and Inozyme Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Inozyme Pharma

The main advantage of trading using opposite Dupont De and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.
The idea behind Dupont De Nemours and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments